New Insights into the Placebo and Nocebo Responses

In modern medicine, the placebo response or placebo effect has often been regarded as a nuisance in basic research and particularly in clinical research. The latest scientific evidence has demonstrated, however, that the placebo effect and the nocebo effect, the negative effects of placebo, stem from highly active processes in the brain that are mediated by psychological mechanisms such as expectation and conditioning. These processes have been described in some detail for many diseases and treatments, and we now know that they can represent both strength and vulnerability in the course of a disease as well as in the response to a therapy. However, recent research and current knowledge raise several issues that we shall address in this review. We will discuss current neurobiological models like expectation-induced activation of the brain reward circuitry, Pavlovian conditioning, and anxiety mechanisms of the nocebo response. We will further explore the nature of the placebo responses in clinical trials and address major questions for future research such as the relationship between expectations and conditioning in placebo effects, the existence of a consistent brain network for all placebo effects, the role of gender in placebo effects, and the impact of getting drug-like effects without drugs.

[1]  R Ader,et al.  Behaviorally Conditioned Immunosuppression , 1974, Psychosomatic medicine.

[2]  M. Honda,et al.  Expectation of Pain Enhances Responses to Nonpainful Somatosensory Stimulation in the Anterior Cingulate Cortex and Parietal Operculum/Posterior Insula: an Event-Related Functional Magnetic Resonance Imaging Study , 2000, The Journal of Neuroscience.

[3]  G. Pagnoni,et al.  Does Anticipation of Pain Affect Cortical Nociceptive Systems? , 2002, The Journal of Neuroscience.

[4]  W. Chey,et al.  Long-Term Safety and Efficacy of Alosetron in Women with Severe Diarrhea-Predominant Irritable Bowel Syndrome , 2004, The American Journal of Gastroenterology.

[5]  D. Wendler,et al.  Deception in Research on the Placebo Effect , 2005, PLoS medicine.

[6]  H. Fields,et al.  THE MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.

[7]  Satoshi Minoshima,et al.  Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans , 1998, Pain.

[8]  Luana Colloca,et al.  Overt versus covert treatment for pain, anxiety, and Parkinson's disease , 2004, The Lancet Neurology.

[9]  D. Volc,et al.  Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen – eine randomisierte kontrollierte Studie , 2006, Wiener klinische Wochenschrift.

[10]  H. Flor,et al.  Classical conditioning and expectancy in placebo hypoalgesia: A randomized controlled study in patients with atopic dermatitis and persons with healthy skin , 2007, Pain.

[11]  Pierre Rainville,et al.  Descending analgesia – When the spine echoes what the brain expects , 2007, PAIN.

[12]  R. Sysko,et al.  A systematic review of placebo response in studies of bipolar mania. , 2007, The Journal of clinical psychiatry.

[13]  K. Schmidt The Science of the Placebo – Toward an Interdisciplinary Research Agenda , 2010 .

[14]  D. Sackett,et al.  Methods of Blinding in Reports of Randomized Controlled Trials Assessing Pharmacologic Treatments: A Systematic Review , 2006, PLoS medicine.

[15]  Raphaël Porcher,et al.  Methodology for small clinical trials. , 2004, Therapie.

[16]  An examination of the relationships among recalled, expected, and actual intensity and unpleasantness of delayed onset muscle pain. , 2003, The journal of pain : official journal of the American Pain Society.

[17]  S. Willich,et al.  The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain , 2007, PAIN.

[18]  C. Büchel,et al.  Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network , 2006, Pain.

[19]  R. Fuente-Fernández Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease , 2004 .

[20]  A. Hrõbjartsson,et al.  Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment , 2004, Journal of internal medicine.

[21]  J. Doljansky,et al.  Cognitive Performance during Sustained Wakefulness: A Low Dose of Caffeine Is Equally Effective as Modafinil in Alleviating the Nocturnal Decline , 2006, Chronobiology international.

[22]  V. Ramirez-Amaya,et al.  Insular Cortex Lesions Impair the Acquisition of Conditioned Immunosuppression , 1996, Brain, Behavior, and Immunity.

[23]  M. Schedlowski,et al.  Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and β-adrenoceptors , 2002, Journal of Neuroimmunology.

[24]  Ravi S. Menon,et al.  Dissociating pain from its anticipation in the human brain. , 1999, Science.

[25]  M. Schulzer,et al.  Placebo mechanisms and reward circuitry: clues from Parkinson's disease , 2004, Biological Psychiatry.

[26]  F. Benedetti,et al.  How prior experience shapes placebo analgesia , 2006, Pain.

[27]  R. Ader,et al.  Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. , 1982, Science.

[28]  Antonia Barke,et al.  The effects of experimenter characteristics on pain reports in women and men , 2004, Pain.

[29]  R. Porcher,et al.  Méthodologie des essais cliniques de petits effectifs , 2004 .

[30]  M Schulzer,et al.  Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease , 2001, Science.

[31]  Dean Sabatinelli,et al.  Affective picture perception: gender differences in visual cortex? , 2004, Neuroreport.

[32]  Val Hopwood,et al.  The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial , 2003, Pain.

[33]  A. Hrõbjartsson,et al.  Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. , 2001, The New England journal of medicine.

[34]  J M Lachin,et al.  The use of response-adaptive designs in clinical trials. , 1993, Controlled clinical trials.

[35]  Luana Colloca,et al.  Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus , 2004, Nature Neuroscience.

[36]  E. C. Ritchie,et al.  Gender Differences , 1981, Language in Society.

[37]  S. Austin SUSPENDED JUDGMENT Memories of the British Streptomycin Trial in Tuberculosis The First Randomized Clinical Trial , 1990 .

[38]  P. Enck,et al.  Psychobiology of the placebo response , 2006, Autonomic Neuroscience.

[39]  A. Bendesky,et al.  On Schleppfuss' path: the placebo response in human evolution. , 2005, Medical hypotheses.

[40]  F. Benedetti Mechanisms of placebo and placebo-related effects across diseases and treatments. , 2008 .

[41]  P. Duffey,et al.  Conditioned immune response to interferon-γ in humans , 1999 .

[42]  G. Fricchione,et al.  Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[43]  Howard L Fields,et al.  Isolating the Modulatory Effect of Expectation on Pain Transmission: A Functional Magnetic Resonance Imaging Study , 2006, The Journal of Neuroscience.

[44]  William F Rosenberger,et al.  Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes , 2006, Biometrics.

[45]  A. Finset,et al.  Cognitive and emotional factors in placebo analgesia. , 2006, Journal of psychosomatic research.

[46]  J. R Gibbs,et al.  TREATMENT OF EXCESSIVE AXILLARY SWEATING , 1974 .

[47]  M. Schedlowski,et al.  Conditioning in the rat: an in vivo model to investigate the molecular mechanisms and clinical implications of brain–immune communication , 2001, Immunological reviews.

[48]  E. Sternberg Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens , 2006, Nature Reviews Immunology.

[49]  Paul J Laurienti,et al.  The subjective experience of pain: where expectations become reality. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Zubieta,et al.  Placebo effects on human μ-opioid activity during pain , 2007, Proceedings of the National Academy of Sciences.

[51]  P. Petrovic,et al.  Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network , 2002, Science.

[52]  S. Donath,et al.  Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation , 1998, Journal of Neuroimmunology.

[53]  A. Stoessl,et al.  Understanding the Placebo Effect: Contributions from Neuroimaging , 2007, Molecular Imaging and Biology.

[54]  Patrizia Baraldi,et al.  Functional activity mapping of the mesial hemispheric wall during anticipation of pain , 2003, NeuroImage.

[55]  P. Enck,et al.  Neurophysiology and psychobiology of the placebo response , 2008, Current opinion in psychiatry.

[56]  P. Enck,et al.  The placebo response in functional bowel disorders: perspectives and putative mechanisms , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[57]  M. Farré,et al.  Placebo response in the prophylaxis of migraine: A meta‐analysis , 2008, European journal of pain.

[58]  V. Ramirez-Amaya,et al.  Differential Effects of NMDA-Induced Lesions into the Insular Cortex and Amygdala on the Acquisition and Evocation of Conditioned Immunosuppression , 1998, Brain, Behavior, and Immunity.

[59]  F. Benedetti,et al.  Potentiation of placebo analgesia by proglumide , 1995, The Lancet.

[60]  F. Benedetti,et al.  Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region , 2004, Brain Research Bulletin.

[61]  Michael Hauck,et al.  Cortical correlates of false expectations during pain intensity judgments—a possible manifestation of placebo/nocebo cognitions , 2005, Brain, Behavior, and Immunity.

[62]  H. Fields,et al.  Analgesic responses to morphine and placebo in individuals with postoperative pain , 1981, PAIN.

[63]  Thomas E. Nichols,et al.  Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors , 2005, The Journal of Neuroscience.

[64]  H. Fukuyama,et al.  Placebo analgesia: a PET study , 2007, Experimental Brain Research.

[65]  L. Madsen,et al.  Single subject trials as a research instrument in gastrointestinal pharmacology , 2002, Alimentary pharmacology & therapeutics.

[66]  R. Ader Conditioned immunomodulation: Research needs and directions , 2003, Brain, Behavior, and Immunity.

[67]  F. Benedetti,et al.  Opioid-Mediated Placebo Responses Boost Pain Endurance and Physical Performance: Is It Doping in Sport Competitions? , 2007, The Journal of Neuroscience.

[68]  M. Farré,et al.  A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials , 2006, European Journal of Clinical Pharmacology.

[69]  R. Ader,et al.  Conditioning of cyclophosphamide-induced leukopenia in humans. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[70]  A. Nierenberg,et al.  Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? , 2007, Journal of clinical psychopharmacology.

[71]  L. Sandvik,et al.  The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. , 1985, Scandinavian journal of gastroenterology.

[72]  K. Perkins,et al.  Acute Reinforcing Effects of Low-Dose Nicotine Nasal Spray in Humans , 1997, Pharmacology Biochemistry and Behavior.

[73]  Fabrizio Benedetti,et al.  Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective , 2006, Pain.

[74]  S. Stone-Elander,et al.  Anticipatory coping of pain expressed in the human anterior cingulate cortex: a positron emission tomography study , 1999, Neuroscience Letters.

[75]  W. Kennedy The nocebo reaction. , 1961, Medical world.

[76]  M. Hyland,et al.  Dispositional predictors of placebo responding: a motivational interpretation of flower essence and gratitude therapy. , 2007, Journal of psychosomatic research.

[77]  F. Benedetti,et al.  Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses , 2003, The Journal of Neuroscience.

[78]  Robert A. Koeppe,et al.  Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects , 2007, Neuron.

[79]  A. Mikami,et al.  Nociceptive neurons in the macaque anterior cingulate activate during anticipation of pain , 1998, Neuroreport.

[80]  C. Porro,et al.  Experimental designs and brain mapping approaches for studying the placebo analgesic effect , 2008, European Journal of Applied Physiology.

[81]  D. Price,et al.  Revelation of a personal placebo response: Its effects on mood, attitudes and future placebo responding , 2007, PAIN.

[82]  A. Zinsmeister,et al.  Predictors of the placebo response in functional dyspepsia , 2006, Alimentary pharmacology & therapeutics.

[83]  U. Dirnagl,et al.  Central nervous system injury-induced immune deficiency syndrome , 2005, Nature Reviews Neuroscience.

[84]  R. Gomeni,et al.  Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. , 2007, British journal of clinical pharmacology.

[85]  D. Price Psychological and neural mechanisms of the affective dimension of pain. , 2000, Science.

[86]  F. Benedetti,et al.  Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems , 1999, The Journal of Neuroscience.

[87]  S. Klosterhalfen,et al.  Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats. , 1990, Behavioral neuroscience.

[88]  Stein Knardahl,et al.  Placebo-Induced Changes in Spinal Cord Pain Processing , 2006, The Journal of Neuroscience.

[89]  G. Schwartz,et al.  Placebo Theory, Research , and Mechanisms , 1985 .

[90]  Luana Colloca,et al.  Placebos and painkillers: is mind as real as matter? , 2005, Nature Reviews Neuroscience.

[91]  V. Sossi,et al.  Dopamine release in human ventral striatum and expectation of reward , 2002, Behavioural Brain Research.

[92]  F. Benedetti The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia , 1996, Pain.

[93]  R G Hill,et al.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.

[94]  Behaviorally Conditioned Immunosuppression , 1974 .

[95]  M. Schedlowski,et al.  Conditioned suppression of contact sensitivity is independent of sympathetic splenic innervation. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[96]  Edward E. Smith,et al.  Placebo-Induced Changes in fMRI in the Anticipation and Experience of Pain , 2004, Science.

[97]  Fabrizio Benedetti,et al.  A comprehensive review of the placebo effect: recent advances and current thought. , 2008, Annual review of psychology.

[98]  U. Wiesing,et al.  International Ethical Regulations on Placebo-Use in Clinical Trials: A Comparative Analysis , 2007, Bioethics.

[99]  F. Benedetti,et al.  Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region , 2005, Brain, Behavior, and Immunity.

[100]  D. Price,et al.  Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. , 2006, The journal of pain : official journal of the American Pain Society.

[101]  U. Dirnagl,et al.  CENTRAL NERVOUS SYSTEM INJURYINDUCED IMMUNE DEFICIENCY SYNDROME , 2005 .

[102]  A. Leuchter,et al.  Changes in brain function of depressed subjects during treatment with placebo. , 2002, The American journal of psychiatry.

[103]  T. Kaptchuk,et al.  The placebo effect in irritable bowel syndrome trials: a meta‐analysis 1 , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[104]  H. Guess The science of the placebo : toward an interdisciplinary research agenda , 2002 .

[105]  C. Viscoli,et al.  Treatment adherence and risk of death after a myocardial infarction , 1990, The Lancet.

[106]  F. Benedetti,et al.  When words are painful: Unraveling the mechanisms of the nocebo effect , 2007, Neuroscience.

[107]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[108]  A Jon Stoessl,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Placebos and the Placebo Effect the Placebo Effect in Neurological Disorders , 2022 .

[109]  K. Tracey Physiology and immunology of the cholinergic antiinflammatory pathway. , 2007, The Journal of clinical investigation.

[110]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[111]  W. Schimetta,et al.  [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial]. , 2006, Wiener klinische Wochenschrift.

[112]  A. Sclafani,et al.  The Role of Gastric and Postgastric Sites in Glucose-Conditioned Flavor Preferences in Rats , 1997, Physiology & Behavior.

[113]  U. Hengge,et al.  Behavioral Conditioning of Antihistamine Effects in Patients with Allergic Rhinitis , 2008, Psychotherapy and Psychosomatics.

[114]  A. Canbay,et al.  Behavioral conditioning of immunosuppression is possible in humans , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[115]  Mario Beauregard,et al.  Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect , 2007, Progress in Neurobiology.

[116]  U. Mitzdorf,et al.  Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials , 2007, BMC medicine.

[117]  M. Mandelkern,et al.  Gender differences in regional brain response to visceral pressure in IBS patients , 2000, European journal of pain.

[118]  Eric R Muth,et al.  Nausea induced by vection drum: contributions of body position, visual pattern, and gender. , 2008, Aviation, space, and environmental medicine.

[119]  M. Cheang,et al.  Defining the predictors of the placebo response in irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[120]  Pierre Rainville,et al.  Direct Comparison of Placebo Effects on Clinical and Experimental Pain , 2006, The Clinical journal of pain.

[121]  R. Dolan,et al.  A Functional Anatomy of Anticipatory Anxiety , 1999, NeuroImage.

[122]  Peter C Gøtzsche,et al.  Data extraction errors in meta-analyses that use standardized mean differences. , 2007, JAMA.

[123]  H. Mcdonald,et al.  Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders? , 2004, Journal of psychiatric research.

[124]  W. Schimetta,et al.  624 BENEFITS OF AN ADD‐ON TREATMENT WITH THE SYNTHETIC CANNABINOMIMETIC NABILONE ON PATIENTS WITH CHRONIC PAIN‐A RANDOMIZED CONTROLLED TRIAL , 2006 .

[125]  Robert A Koeppe,et al.  Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. , 2008, Archives of general psychiatry.

[126]  小山 哲男 Nociceptive neurons in the macaque anterior cingulate activate during anticipation of pain , 2000 .

[127]  S. Donath,et al.  Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. , 1999, The American journal of physiology.

[128]  P. Duffey,et al.  Conditioned immune response to interferon-gamma in humans. , 1999, Clinical Immunology.

[129]  Reynold A Panettieri,et al.  Placebo response in asthma: a robust and objective phenomenon. , 2007, The Journal of allergy and clinical immunology.

[130]  R. A. Koelling,et al.  Conditioned aversion to saccharin resulting from exposure to gamma radiation. , 1955, Science.

[131]  A. Stoessl,et al.  The placebo effect in Parkinson's disease , 2002, Trends in Neurosciences.

[132]  C. Kirschbaum,et al.  Sex-specific adaptation of endocrine and inflammatory responses to repeated nauseogenic body rotation , 2006, Psychoneuroendocrinology.

[133]  J. Riley,et al.  A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia , 2002, Pain.

[134]  Kennedy Wp The nocebo reaction. , 1961 .

[135]  R. Rescorla,et al.  Extinction of Pavlovian conditioned inhibition. , 1974, Journal of comparative and physiological psychology.

[136]  K. Någren,et al.  Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia , 2005, Neuroscience Letters.

[137]  W. Schultz,et al.  Discrete Coding of Reward Probability and Uncertainty by Dopamine Neurons , 2003, Science.

[138]  F. Benedetti Cholecystokinin Type A and Type B Receptors and Their Modulation of Opioid Analgesia , 1997 .

[139]  William L. Kelemen,et al.  Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design. , 2007, Experimental and clinical psychopharmacology.

[140]  A. Raz Genetics and Neuroimaging of Attention and Hypnotizability May Elucidate Placebo , 2007, The International journal of clinical and experimental hypnosis.

[141]  Manfred Schedlowski,et al.  Behavioural Conditioning of Immune Functions: How the Central Nervous System Controls Peripheral Immune Responses by Evoking Associative Learning Processes , 2008, Reviews in the neurosciences.

[142]  B. Rostkowska-Nadolska [Can the placebo be the cure?]. , 2007, Wiadomosci lekarskie.

[143]  Michael Forsting,et al.  There are differences in cerebral activation between females in distinct menstrual phases during viewing of erotic stimuli: a fMRI study , 2006, Experimental Brain Research.

[144]  S. Cole-Harding,et al.  Does expectancy affect alcohol absorption? , 2007, Addictive behaviors.

[145]  M. Schedlowski,et al.  Neural Substrates for Behaviorally Conditioned Immunosuppression in the Rat , 2005, The Journal of Neuroscience.

[146]  M. Vangel,et al.  Brain Activity Associated with Expectancy-Enhanced Placebo Analgesia as Measured by Functional Magnetic Resonance Imaging , 2006, The Journal of Neuroscience.

[147]  H. Engler,et al.  Named Series: Brain Mechanisms of Placebo Expectations and associations that heal: Immunomodulatory placebo eVects and its neurobiology , 2006 .

[148]  R. de la Fuente-Fernández Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. , 2004, Parkinsonism & related disorders.

[149]  L. Chang,et al.  A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation , 2005, Gut.

[150]  R. Hahn,et al.  The nocebo phenomenon: concept, evidence, and implications for public health. , 1997, Preventive medicine.

[151]  R. Lilford,et al.  The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls , 2005, World Journal of Surgery.

[152]  Anna C. Balazs,et al.  Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. , 1980, The New England journal of medicine.